The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

Go back to The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023

The Oncology Institute, Inc. (TOI) Tops Q4 EPS by 5c, Offers Guidance

March 9, 2023 4:44 PM EST

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $71.4 million versus the consensus estimate of $64.73 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2023 revenue of $290-320... More